Helicobacter Pylori: The Cancer Link

Parkin D.M. , Pisani P. , Fearly J. Estimates of worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594–606.

Rugge M. , Sonego F. , Panozzo M. Pathology and ploidy in the prognosis of gastric cancer with no extranodal metastasis. Cancer 1994; 73: 1127–33.

Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965; 64: 31–49.

Correa P. A human model of gastric carcinogenesis. Cancer Res 1988; 48: 3554–66.

Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res 1992; 52: 6735–40.

International Agency for Research on Cancer. Schistosomes, Liver Flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans, vol 61, Lyon: IARC, 1994

Perez-Perez G.I. , Taylor D.N. , Bodhidatta L. Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Disease 1990; 161: 1237–41.

EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1994; 341: 1359–62.

The Gastrointestinal Physiology Working Group. Helicobacter pylori and gastritis in Peruvian patients: relationship to socioeconomic level, age and sex. Am J Gastroenterol 1990; 85: 819–23.

Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol Clin N Am 1993; 22: 89–104.

Sipponen P. , Seppälä K. Long-term consequences of H. pylori infection: time trends in H. pylori gastritis, gastric cancer and peptic ulcer disease. In: Hunt RH , Tytgat GNJ , eds. Helicobacter pylori: Basic Mechanisms to Clinical Cure. Boston: Kluwer 1994: 372–80

Parsonnet D.M. , Friedman G.T. , Vandersteen D.P. Helicobacter pylori infection and risk for gastric carcinoma. N Engl J Med 1991; 325: 1127–31.

Forman D. , Newell D.G. , Fullerton F. Association between infection with Helicobacter pylori and risk of gastric cancer; evidence of a prospective investigation. BMJ 1991; 302: 1302–5.

Nomura A. , Stemmerman G.N. , Chyou P.H. , Kato I. , Perez-Perez G.L. , Blaser M.J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132–6.

Forman D. , Webb P. , Parsonnet J. Helicobacter pylori and gastric cancer. Lancet 1994; 343: 243–4.

Tally N.J. , Zinsmeister A.R. , Weaver A. , Dimagno E.P. , Carpenter H.A. , Perez-Perez G.L. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991; 83: 1734–9.

Sipponen P. , Kosunen T.U. , Valle J. , Riihela M. , Seppälä K. Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 1992; 45: 319–23.

Hansson L.E. , Engstrand L. , Nyren O.L. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993; 105: 1098–103.

Kuipers E] , Gracia-Casanova M. , Pena A.S. Helicobacter pylori serology in patients with gastric carcinoma. Scand J Gastroenterol 1993; 28: 433–7.

Warren J.R. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; i: 1273–5.

Blaser M.J. Gastric Campylobacter-like organisms, gastritis and peptic ulcer disease. Gastroenterology 1987; 93: 371–83.

Rauws E.A.J. , Langenberg W. , Houthoff H.J. , Zanen H.C. , Tytgat G.N.J. Campylobacter phloridis-associated active antral gastritis: a prospective study of its prevalence and the effect on anti-bacterial and anti-ulcer treatment. Gastroenterology 1988; 94: 33–40.

Dixon M.F. Campylobacter pylori and chronic gastritis. In: Rathbone B.J. , Heatley R.V. , eds. Campylobacter pylori and Gastroduodenal Disease. Oxford: Blackwell Scientific Publications, 1989: 106–16

Craanen M.E. , Blok P. , Dekker W. , Fewerda J. , Tytgat G.N.J. Intestinal metaplasia and Helicobacter pylori: an endoscopic-bioptic study of the antrum. Gut 1992; 33: 16–20.

Filipe M.I. Histochemistry of intestinal mucins. In: Whitehead R , ed. Gastrointestinal and Oesophageal Pathology. Edinburgh: Churchill Livingstone, 1989: 71

Rokkas T. , Filipe M.I. , Sladen G.E. Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 1991; 32: 1110–13

O'Connor F. , Sweeney E. , O'Morain C. Helicobacter pylon and subtypes of intestinal metaplasia in gastric antral mucosa. Irish J Med Sci 1995; 74: 225–6.

Gilvarry J.M. , Leen E. , Sweeney E. , O'Morain C. The long term effect of Helicobacter pylori on gastric mucosa. Eur J Gastroenterol Hepatol 1994; 6: 43–5.

Fujiwara Y. , Kang J. , Fujiwara K. , Chang K. , Tarnawksi A. Effects of non-steroidal anti-inflammatory drugs on cell proliferation in gastroduodenal mucosa. A review article. Eur J Gastroenterol Hepatol 1993; 5: 301–5.

Broek D. , Bartlett R. , Crawford K. , Nurse P. Involvement of p34^cdc2 in establishing the dependency of S phase on mitosis. Nature 1991; 349: 388–93.

Hollywood D.P. , Lemoine N.R. Growth factors, oncogenes and tumour suppressor genes. In: Hall P , Levison DA , Wright NA , eds. Assessment of Cell Proliferation in Clinical Practice. London: Springer-Verlag, 1992: 27–41

Cahill R.J. , Sant S. , Beattie S. , Hamilton H. , O'Morain C. Helicobacter pylori and increased epithelial cell proliferation: a risk factor for cancer. Eur J Gastroenterol Hepatol 1994; 6: 1123–8.

Cahill R.J. , Sant S. , Beattie S. , Hamilton H. , O'Morain C. Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. Dig Dis Sci 1995; 40: 1627–31.

Cahill R.J. , Kilgallen C. , Beattie S. , Hamilton H. , O'Morain C. Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma. Gut 1996; 38: 177–81.

Freeman J.T. , Hafkesbring R. Comparative studies of ascorbic acid levels in gastric secretion and blood. Gastroenterology 1957; 32: 878–86.

Hansson L.E. , Myren O. , Bergstrom R. Nutrients and gastric cancer risk. A population based control study in Sweden, Int J Cancer 1994; 57: 638–44.

O'Connor H.J. , Schorah C.J. , Habibzedah N. , Axon A.T.R. , Cockel R. Vitamin C in the human stomach: relation to gastric pH, gastroduodenal disease and possible sources. Gut 1989; 30: 436–42.

Bannerjee S. , Hawksby C. , Miller S. , Dahill S. , Beattie A.D. , McColl K.E.L. Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut 1994; 35: 317–22.

Correa P. , Haenszel W. , Cuello C. , Tannenbaum S.R. , Archer M. A model for gastric cancer epidemiology. Lancet 1975; ii: 58–60.

Koningsberger J.C. , Marx J.J.M. , Van Hattum J. Free radicals in gastroenterology. Scand J Gastroenterol 1988; 23(suppl 154): 30–40

Drake I.M. , Warland D. , Carswell N. Reactive oxygen species (ROS) activity and damage in Helicobacter pylori/ori-associatcd gastritis (HPG)-cffect of eradication therapy. Gut 1995; 37(suppl 1): A155

Crabtree J.E. , Taylor J.D. , Wyatt J.I. Mucosal IgA recognition of Helicobacter pylori 120kDa protein, peptic ulceration and gastric pathology. Lancet 1991; 338: 332–5.

Crabtree J.E. , Farmery S. , Lindley I.J.D. , Peichl P. , Tompkins D.S. Cytotoxic strains of Helicobacter pylori induce IL-8 production form gastric epithelial cells (Abstr). Acta Gastroenterol Belg 1993; 56(suppl): 48

Crabtree J.E. , Wyatt J.I. , Trejdosiewicz L.K. Interleukin 8 expression in Helicobacter pylori infected, normal and neoplastic gastroduodenal mucosa. J Clin Pathol 1994; 47: 61–7.

Wyatt J.I. , Rathbone B.J. Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol 1989; 23(suppl 154): 44–9

Telford J.L. , Ghiara P. , Dell'orco M. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994; 179: 1653–8.

Atherton J.C. , Cover T.L. , Ray K.C. , Peek R.M. , Perez-Perez G.I. , Blaser M.J. Genotypic analysis of vacA and cagA in Helicobacter pylori isolates from the U.S., Thailand, Peru and China. Gut 1995; 37(suppl 1): A275

Stolte M. , Edti S. Lymphoid follicles in the antral mucosa: immune response to Campylobacter pylori. J Clin Pathol 1989; 42: 1269–71.

Parsonnet J. , Hansen S. , Rodriguez L. Helicobacter pylori infection in gastric lymphoma. N Engl J Med 1994; 330: 1267–71.

Hussell T. , Isaacson P.G. , Crabtree J.E. The response of cells from low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342: 571–4.

Wotherspoon A.C. , Doglioni C. , Diss T.C. Regression of primary low-grade-B-cell lymphoma of mucosa-associated lymphoid tissue after eradication of Helicobacter pylori. Lancet 1993; 342: 575–7.

Bayerdörfler E. , Neubauer A. , Rudolph B. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995; 345: 1591–4.

Buckley M. , Hamilton H. , Beattie S. , O'Morain C. A simplified reliable urea breath test. Gut 1995; 37(suppl 1): A242